ClinicalTrials.Veeva

Menu

The Effect and Mechanism of lncRNA NBR2 Regulating Endothelial Pyroptosis by Targeting GSDMD in Sepsis

J

Jianfeng Xie

Status

Unknown

Conditions

Sepsis

Treatments

Other: the levels of pyroptosis

Study type

Observational

Funder types

Other

Identifiers

NCT04427371
SoutheastUChina

Details and patient eligibility

About

Sepsis is a life-threatening disease characterized by multi-organ failure due to dysregulated host response to infection, with high global mortality of 30-50%. One of the most important pathophysiologic hallmarks in sepsis is vascular endothelial injury that contributes to the severity and outcome of the syndrome. Effective treatments for endothelial cell injury in sepsis have been lacking to improve prognosis. Endothelial pyroptosis is a vital mechanism of vascular endothelial injury in sepsis; mitigation or abolishment of endothelial cell pyroptosis alleviate vascular endothelial damage and improve the prognosis of sepsis mice. Gasdermin D (GSDMD) mediated endothelial pyroptosis plays a critical role in modulating vascular endothelial injury in sepsis.

Long non-coding RNA (lncRNA), as a class of non-coding protein RNA longer than 200 kD, contributes to a variety of cell biological processes. The dysregulation of lncRNA results in the occurrence and development of tumors, diabetes, sepsis and other diseases. Therefore, we detected lncRNA and mRNA expression profile in 26 blood samples of septic patients using Arraystar LncRNA Microarray. We found lncRNA NBR2 regulates septic endothelial pyroptosis.

To assess any correlation of pyroptosis levels with relevant endothelial cell injury parameters and determine the prognostic value in septic patients. we measured the levels of pyroptosis in patients admitted to the Department of Critical Care Medicine for sepsis and investigated the correlation with related markers of endothelium injury. Furthermore, we determined the prognostic value of pyroptosis levels for the mortality of patients with sepsis.

Full description

We measured the levels of pyroptosis in patients admitted to the Department of Critical Care Medicine for sepsis and investigated the correlation with related markers of endothelium injury. Furthermore, we determined the prognostic value of pyroptosis levels for the mortality of patients with sepsis.

Enrollment

100 estimated patients

Sex

All

Ages

18 to 80 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Suspected or confirmed infection
  • The sequential organ failure score (SOFA score) increases by more than or equal to 2 points on the basis
  • Sign the informed consent

Exclusion criteria

  1. the age < 18 or > 80 years of age
  2. pregnant
  3. tumor
  4. viral hepatitis or liver cirrhosis
  5. chronic renal tubular nephritis, chronic renal insufficiency
  6. ulcerative colitis or crohn's disease
  7. active systemic lupus erythematosus (SLE)
  8. acute myocardial infarction
  9. acute pancreatitis
  10. engaged in other clinical subjects

Trial design

100 participants in 2 patient groups

survivors
Description:
Improve or under treatment
Treatment:
Other: the levels of pyroptosis
nonsurvivors
Description:
all-cause 28-day mortality
Treatment:
Other: the levels of pyroptosis

Trial contacts and locations

1

Loading...

Central trial contact

Yi Yang, Prof.; Fei Peng, Dr

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems